Patient Perceptions of Deprescribing: Survey Development and Psychometric Assessment
- PMID: 27579916
- PMCID: PMC6788283
- DOI: 10.1097/MLR.0000000000000642
Patient Perceptions of Deprescribing: Survey Development and Psychometric Assessment
Abstract
Background: Although clinicians ultimately decide when to discontinue (deprescribe) medications, patients' perspectives may guide the process.
Objectives: To develop a survey instrument that assesses patients' experience with and attitudes toward deprescribing.
Research design: We developed a questionnaire with established and newly created items. We used exploratory factor analysis and confirmatory factor analysis (EFA and CFA) to assess the psychometric properties.
Subjects: National sample of 1547 Veterans Affairs patients prescribed ≥5 medications.
Measures: In the EFA, percent variance, a scree plot, and conceptual coherence determined the number of factors. In the CFA, proposed factor structures were evaluated using standardized root mean square residual, root mean square error of approximation, and comparative fit index.
Results: Respondents (n=790; 51% response rate) were randomly assigned to equal derivation and validation groups. EFA yielded credible 4-factor and 5-factor models. The 4 factors were "Medication Concerns," "Provider Knowledge," "Interest in Stopping Medicines," and "Unimportance of Medicines." The 5-factor model added "Patient Involvement in Decision-Making." In the CFA, a modified 5-factor model, with 2 items with marginal loadings moved based upon conceptual fit, had an standardized root mean square residual of 0.06, an RMSEA of 0.07, and a CFI of 0.91. The new scales demonstrated internal consistency reliability, with Cronbach α's of: Concerns, 0.82; Provider Knowledge, 0.86; Interest, 0.77; Involvement, 0.61; and Unimportance, 0.70.
Conclusions: The Patient Perceptions of Deprescribing questionnaire is a novel, multidimensional instrument to measure patients' attitudes and experiences related to medication discontinuation that can be used to determine how to best involve patients in deprescribing decisions.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Cross-cultural adaptation and psychometric validation of a Spanish version of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire.BMJ Open. 2022 Apr 21;12(4):e050678. doi: 10.1136/bmjopen-2021-050678. BMJ Open. 2022. PMID: 35450888 Free PMC article.
-
The Patient Perceptions of Deprescribing (PPoD) Survey: Short-Form Development.Drugs Aging. 2020 Dec;37(12):909-916. doi: 10.1007/s40266-020-00802-w. Epub 2020 Oct 7. Drugs Aging. 2020. PMID: 33026638
-
Predictors of medicine-related perceptions towards deprescribing inappropriate medications among older adult outpatients in Jordan: a cross-sectional study.BMJ Open. 2024 Nov 24;14(11):e086207. doi: 10.1136/bmjopen-2024-086207. BMJ Open. 2024. PMID: 39581713 Free PMC article.
-
Development and validation of a tool to understand health care professionals' attitudes towards deprescribing (HATD) in older adults with limited life expectancy.Res Social Adm Pharm. 2022 Sep;18(9):3596-3601. doi: 10.1016/j.sapharm.2022.03.002. Epub 2022 Mar 8. Res Social Adm Pharm. 2022. PMID: 35296385 Review.
-
Deprescribing medications in older people: a narrative review.Drugs Today (Barc). 2018 Aug;54(8):489-498. doi: 10.1358/dot.2018.54.8.2856495. Drugs Today (Barc). 2018. PMID: 30209443 Review.
Cited by
-
Cross-cultural adaptation and psychometric validation of a Spanish version of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire.BMJ Open. 2022 Apr 21;12(4):e050678. doi: 10.1136/bmjopen-2021-050678. BMJ Open. 2022. PMID: 35450888 Free PMC article.
-
Health-related preferences of older patients with multimorbidity: an evidence map.BMJ Open. 2019 Dec 15;9(12):e034485. doi: 10.1136/bmjopen-2019-034485. BMJ Open. 2019. PMID: 31843855 Free PMC article.
-
Patient-Reported Barriers and Enablers to Deprescribing Recommendations During a Clinical Trial (Shed-MEDS).Gerontologist. 2023 Mar 21;63(3):523-533. doi: 10.1093/geront/gnac100. Gerontologist. 2023. PMID: 35881109 Free PMC article. Clinical Trial.
-
Improving care for elderly patients living with polypharmacy: protocol for a pragmatic cluster randomized trial in community-based primary care practices in Canada.Implement Sci. 2019 Jun 6;14(1):55. doi: 10.1186/s13012-019-0904-4. Implement Sci. 2019. PMID: 31171011 Free PMC article. Clinical Trial.
-
Deprescribing one year on: challenging the first iatrogenic epidemic.Eur J Hosp Pharm. 2018 Mar;25(2):63-64. doi: 10.1136/ejhpharm-2017-001482. Epub 2018 Jan 27. Eur J Hosp Pharm. 2018. PMID: 31156989 Free PMC article. No abstract available.
References
-
- Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140:795–801. - PubMed
-
- Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556–1564. - PubMed
-
- Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175: 827–834. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous